Viewing Study NCT02255968


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2026-02-21 @ 11:19 PM
Study NCT ID: NCT02255968
Status: TERMINATED
Last Update Posted: 2015-05-12
First Post: 2014-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788
Sponsor: Enanta Pharmaceuticals, Inc
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-08
Start Date Type: None
Primary Completion Date: 2014-10
Primary Completion Date Type: ACTUAL
Completion Date: 2014-10
Completion Date Type: ACTUAL
First Submit Date: 2014-07-29
First Submit QC Date: None
Study First Post Date: 2014-10-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-05-08
Last Update Post Date: 2015-05-12
Last Update Post Date Type: ESTIMATED